NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD
ILLUMINA INC
NASDAQ:ILMN (2/4/2025, 8:00:02 PM)
After market: 124.25 +0.05 (+0.04%)124.2
-6.9 (-5.26%)
The current stock price of ILMN is 124.2 USD. In the past month the price decreased by -8.68%. In the past year, price decreased by -9.9%.
Trump signs maximum pressure sanctions on Iran, citing nuclear ambitions and support for militants. Doubles down on China trade stance.
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.3% in the afternoon session after China put the company on its "unreliable entity" list, opening the door to possible sanctions. The move came after the Trump administration slapped a 10% tariff on Chinese goods. Financial filings in 2024 revealed that Illumina makes about 7% of its sales from China, and it's unclear whether China's action is a short-term reaction or one with longer consequences.
Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.3% in the afternoon session after China put the company on its "unreliable entity" list, opening the door to possible sanctions. The move came after the Trump administration slapped a 10% tariff on Chinese goods. Financial filings in 2024 revealed that Illumina makes about 7% of its sales from China, and it's unclear whether China's action is a short-term reaction or one with longer consequences.
The firms were singled out by China soon after Trump's tariffs rolled out
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 26.56 | 222.07B | ||
DHR | DANAHER CORP | 28.71 | 155.30B | ||
A | AGILENT TECHNOLOGIES INC | 27.8 | 41.93B | ||
IQV | IQVIA HOLDINGS INC | 18.42 | 36.31B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 35.12 | 28.27B | ||
WAT | WATERS CORP | 36.03 | 24.37B | ||
WST | WEST PHARMACEUTICAL SERVICES | 48.97 | 23.97B | ||
ICLR | ICON PLC | 13.78 | 15.96B | ||
RVTY | REVVITY INC | 25.13 | 14.99B | ||
AVTR | AVANTOR INC | 22.46 | 14.98B | ||
TECH | BIO-TECHNE CORP | 40.53 | 11.53B | ||
MEDP | MEDPACE HOLDINGS INC | 30.38 | 10.78B |
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 10,590 full-time employees. The company went IPO on 2000-06-28. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. The company is also a developer of an emerging and highly differentiated single-cell technology.
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122 US
CEO: Francis A. deSouza
Employees: 10615
Company Website: https://www.illumina.com
Investor Relations: https://investor.illumina.com
Phone: 18582024500
The current stock price of ILMN is 124.2 USD.
The exchange symbol of ILLUMINA INC is ILMN and it is listed on the Nasdaq exchange.
ILMN stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ILMN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ILMN.
ILMN does not pay a dividend.
ILMN will report earnings on 2025-02-06, after the market close.
The PE ratio for ILMN is 71.79. This is based on the reported non-GAAP earnings per share of 1.73 and the current share price of 124.2 USD.
The outstanding short interest for ILMN is 3.77% of its float.
ChartMill assigns a fundamental rating of 4 / 10 to ILMN. While ILMN seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 1.73. The EPS decreased by 98.85% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.34% | ||
ROE | -74.54% | ||
Debt/Equity | 0.94 |
ChartMill assigns a Buy % Consensus number of 76% to ILMN. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 384.01% and a revenue growth -3.66% for ILMN